Clinical Trial Update: Effect of Interleukin-6 Receptor Inhibition in Patients With Ischemic Stroke Undergoing Endovascular Treatment [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating interleukin-6 receptor inhibition in ischemic stroke patients undergoing endovascular treatment has completed. The excerpt notes comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Snippet

Sponsor: Suzhou Municipal Hospital of Anhui Province | Conditions: Interleukin-6, Ischemic Stroke | Phase 2, Phase 3 | Status: COMPLETED